Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Seek medical attention immediately at the first sign of any adverse drug reaction. If symptoms persist, consult a doctor.